Skip to main content
logo
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.980
+0.093 (4.93%)
May 22, 2026, 4:00 PM EDT - Market closed

Serina Therapeutics Revenue

Serina Therapeutics had revenue of $130.00K in the twelve months ending March 31, 2026, up 154.90% year-over-year. In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.

Revenue (ttm)
$130.00K
Revenue Growth
+154.90%
P/S Ratio
226.92
Revenue / Employee
$10,000
Employees
13
Market Cap
29.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025130.00K74.00K132.14%
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M3.12M9,173.53%
Dec 31, 202234.00K-110.00K-76.39%
Dec 31, 2021144.00K-217.00K-60.11%
Dec 31, 2020361.00K-1.37M-79.11%
Dec 31, 20191.73M332.00K23.78%
Dec 31, 20181.40M-8.00K-0.57%
Dec 31, 20171.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Celularity26.55M
Dyadic International3.81M
Traws Pharma2.73M
Pluri1.08M
Vistagen Therapeutics789.00K
Neuphoria Therapeutics-13.27K
Revenue Rankings

SER News

More News